ARDIZZONE, Alessio
 Distribuzione geografica
Continente #
NA - Nord America 651
EU - Europa 600
AS - Asia 190
SA - Sud America 3
AF - Africa 2
Totale 1.446
Nazione #
US - Stati Uniti d'America 648
IE - Irlanda 229
IT - Italia 155
SE - Svezia 133
SG - Singapore 113
CN - Cina 52
DE - Germania 21
AT - Austria 13
IN - India 13
FI - Finlandia 12
NL - Olanda 8
FR - Francia 5
ID - Indonesia 5
UA - Ucraina 5
BE - Belgio 4
CZ - Repubblica Ceca 4
CH - Svizzera 3
JP - Giappone 3
BR - Brasile 2
CA - Canada 2
GB - Regno Unito 2
HK - Hong Kong 2
SC - Seychelles 2
SK - Slovacchia (Repubblica Slovacca) 2
AE - Emirati Arabi Uniti 1
BG - Bulgaria 1
CL - Cile 1
DK - Danimarca 1
IL - Israele 1
PA - Panama 1
PL - Polonia 1
RO - Romania 1
Totale 1.446
Città #
Dublin 229
Chandler 175
Nyköping 119
Singapore 94
Ashburn 82
Messina 53
New York 49
Boardman 28
Princeton 27
Medford 21
Piazza Armerina 17
Munich 14
Catania 12
Des Moines 12
Washington 11
Vienna 10
Wilmington 10
Helsinki 9
Rome 9
Los Angeles 7
Pune 7
Falls Church 6
Hyderabad 6
Jakarta 5
Tappahannock 5
Cagliari 4
Nuremberg 4
Santa Clara 4
Beijing 3
Brno 3
Brussels 3
Corigliano Calabro 3
Donnalucata 3
Lappeenranta 3
Milan 3
Nanjing 3
Turin 3
Wakayama 3
Xiamen 3
Amsterdam 2
Brembate di Sopra 2
Carini 2
Dnipro 2
Dongguan 2
Ferrara 2
Florence 2
Hangzhou 2
Harbin 2
Hong Kong 2
Jinan 2
Montopoli in Val d'Arno 2
Naaldwijk 2
Ningbo 2
Palermo 2
Paris 2
Senec 2
Shanghai 2
Shijiazhuang 2
Syracuse 2
Toronto 2
Antwerp 1
Biancavilla 1
Boston 1
Bremen 1
Ceska 1
Changzhou 1
Guangzhou 1
Hebei 1
Hengyang 1
Kyiv 1
London 1
Marsala 1
Nanning 1
Napoli 1
Newark 1
Norwalk 1
Pedara 1
Qingdao 1
Rozendaal 1
San Francisco 1
Santa Maria del Cedro 1
Seattle 1
Shenyang 1
Sofia 1
Suyicun 1
São Paulo 1
Taizhou 1
Taranto 1
Tianjin 1
Warsaw 1
Yichun 1
Zhengzhou 1
Zurich 1
Totale 1.137
Nome #
Efficacy of a novel therapeutic, based on natural ingredients and probiotics, in a murine model of multiple food intolerance and maldigestion 67
Co-Ultra PEALut Enhances Endogenous Repair Response Following Moderate Traumatic Brain Injury 64
H1299R Variant in Factor V and Recurrent Pregnancy Loss: A Systematic Review and Meta-Analysis Protocol 63
Evaluation of a Product Containing Xyloglucan and Pea Protein on Skin Barrier Permeability 61
Effect of ultra-micronized-palmitoylethanolamide and acetyl-l-carnitine on experimental model of inflammatory pain 59
Effect of a Product Containing Xyloglucan and Pea Protein on a Murine Model of Atopic Dermatitis 58
KYP-2047, an inhibitor of prolyl-oligopeptidase, reduces glioblastoma proliferation through angiogenesis and apoptosis modulation 52
Therapeutic potential of flavonoids in the treatment of chronic venous insufficiency 50
Role of fibroblast growth factors receptors (FGFRs) in brain tumors, focus on astrocytoma and glioblastoma 49
Beneficial effect of tempol, a membrane-permeable radical scavenger, on inflammation and osteoarthritis in in vitro models 49
Role of miRNA-19a in Cancer Diagnosis and Poor Prognosis 48
null 47
Antioxidant and anti-inflammatory effect of nrf2 inducer dimethyl fumarate in neurodegenerative diseases 45
Efficacy of a Product Containing Xyloglucan and Pea Protein on Intestinal Barrier Function in a Partial Restraint Stress Animal Model 43
Topical delivery of curcumin by choline-calix[4]arene-based nanohydrogel improves its therapeutic effect on a psoriasis mouse model 41
Role of ABT888, a Novel Poly(ADP-Ribose) Polymerase (PARP) Inhibitor in Countering Autophagy and Apoptotic Processes Associated to Spinal Cord Injury 41
Inhibition of Prolyl Oligopeptidase Prevents Consequences of Reperfusion following Intestinal Ischemia 40
Synergic therapeutic potential of PEA-Um treatment and NAAA enzyme silencing in the management of neuroinflammation 39
Neurofibromatosis: New Clinical Challenges in the Era of COVID-19 38
Properties of a new food supplement containing Actinia equina extract 37
The protective role of prolyl oligopeptidase (Pop) inhibition in kidney injury induced by renal ischemia–reperfusion 36
The inhibition of mammalian target of rapamycin (mTOR) in improving inflammatory response after traumatic brain injury 34
Pea-oxa mitigates oxaliplatin-induced painful neuropathy through nf-κb/nrf-2 axis 32
A Systematic Review and Meta-Analysis of the Association between the FV H1299R Variant and the Risk of Recurrent Pregnancy Loss 31
A Combination of Xyloglucan, Pea Protein and Chia Seed Ameliorates Intestinal Barrier Integrity and Mucosa Functionality in a Rat Model of Constipation-Predominant Irritable Bowel Syndrome 30
Ulva pertusa, a Marine Green Alga, Attenuates DNBS-Induced Colitis Damage via NF-κB/Nrf2/SIRT1 Signaling Pathways 28
Evaluation of a Gel Containing a Propionibacterium Extract in an In Vivo Model of Wound Healing 27
A New Approach for the Treatment of Recurrent Vulvovaginal Candidiasis with a Combination of Pea Protein, Grape Seed Extract, and Lactic Acid Assessed In Vivo 26
SCFA Treatment Alleviates Pathological Signs of Migraine and Related Intestinal Alterations in a Mouse Model of NTG-Induced Migraine 26
SUN11602, a bFGF mimetic, modulated neuroinflammation, apoptosis and calcium-binding proteins in an in vivo model of MPTP-induced nigrostriatal degeneration 25
Treatment with luteolin improves lipopolysaccharide‐induced periodontal diseases in rats 25
Efficacy of the Radical Scavenger, Tempol, to Reduce Inflammation and Oxidative Stress in a Murine Model of Atopic Dermatitis 23
Efficacy of a Novel Therapeutic, Based on Natural Ingredients and Probiotics, in a Murine Model of Multiple Food Intolerance and Maldigestion 23
Evaluation of the Efficacy of Xyloglucan, Pea Protein and Opuntia ficus-indica Extract in a Preclinical Model of Psoriasis 18
New Insights into the Mechanism of Ulva pertusa on Colitis in Mice: Modulation of the Pain and Immune System 15
null 15
Rebalancing NOX2/Nrf2 to limit inflammation and oxidative stress across gut-brain axis in migraine 14
The Prognostic Value of Pentraxin-3 in COVID-19 Patients: A Systematic Review and Meta-Analysis of Mortality Incidence 13
Interleukin-21 Influences Glioblastoma Course: Biological Mechanisms and Therapeutic Potential 13
Efficacy of an oral suspension containing xyloglucan and pea proteins on a murine model of gastroesophageal reflux disease 12
Recent Emerging Immunological Treatments for Primary Brain Tumors: Focus on Chemokine-Targeting Immunotherapies 12
Evaluation of the nutraceutical Palmitoylethanolamide in reducing intraocular pressure (IOP) in patients with glaucoma or ocular hypertension: a systematic review and meta-analysis 9
Role of Basic Fibroblast Growth Factor in Cancer: Biological Activity, Targeted Therapies, and Prognostic Value 9
Efficacy of Palmitoylethanolamide and Luteolin Association on Post-Covid Olfactory Dysfunction: A Systematic Review and Meta-Analysis of Clinical Studies 8
Signaling Pathways of AXL Receptor Tyrosine Kinase Contribute to the Pathogenetic Mechanisms of Glioblastoma 8
bFGF-like Activity Supported Tissue Regeneration, Modulated Neuroinflammation, and Rebalanced Ca2+ Homeostasis following Spinal Cord Injury 7
Pentraxin 3: A Main Driver of Inflammation and Immune System Dysfunction in the Tumor Microenvironment of Glioblastoma 6
Recent Emerging Immunological Treatments for Primary Brain Tumors: Focus on Chemokine-Targeting Immunotherapies 6
The Impact of COVID-19 on Amputation and Mortality Rates in Patients with Acute Limb Ischemia: A Systematic Review and Meta-Analysis 5
Dihydropyrimidine Dehydrogenase Polymorphism c.2194G>A Screening Is a Useful Tool for Decreasing Gastrointestinal and Hematological Adverse Drug Reaction Risk in Fluoropyrimidine-Treated Patients 4
Serum Pentraxin 3 as Promising Biomarker for the Long-Lasting Inflammatory Response of COVID-19 4
Novel Findings on CCR1 Receptor in CNS Disorders: A Pathogenic Marker Useful in Controlling Neuroimmune and Neuroinflammatory Mechanisms in Parkinson's Disease 3
Linking GERD and the Peptide Bombesin: A New Therapeutic Strategy to Modulate Inflammatory, Oxidative Stress and Clinical Biochemistry Parameters 3
null 2
Marine Algae and Deriving Biomolecules for the Management of Inflammatory Bowel Diseases: Potential Clinical Therapeutics to Decrease Gut Inflammatory and Oxidative Stress Markers? 1
Totale 1.544
Categoria #
all - tutte 11.614
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.614


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202149 1 3 2 8 0 0 8 8 14 3 1 1
2021/2022195 0 7 13 0 14 6 7 10 14 4 23 97
2022/2023681 48 58 23 61 35 87 8 47 276 11 23 4
2023/2024331 9 32 23 29 26 108 13 18 5 9 11 48
2024/2025288 36 22 55 61 47 66 1 0 0 0 0 0
Totale 1.544